Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

227 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group.
van Wijk FH, Aapro MS, Bolis G, Chevallier B, van der Burg ME, Poveda A, de Oliveira CF, Tumolo S, Scotto di Palumbo V, Piccart M, Franchi M, Zanaboni F, Lacave AJ, Fontanelli R, Favalli G, Zola P, Guastalla JP, Rosso R, Marth C, Nooij M, Presti M, Scarabelli C, Splinter TA, Ploch E, Beex LV, ten Bokkel Huinink W, Forni M, Melpignano M, Blake P, Kerbrat P, Mendiola C, Cervantes A, Goupil A, Harper PG, Madronal C, Namer M, Scarfone G, Stoot JE, Teodorovic I, Coens C, Vergote I, Vermorken JB; European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group. van Wijk FH, et al. Among authors: chevallier b. Ann Oncol. 2003 Mar;14(3):441-8. doi: 10.1093/annonc/mdg112. Ann Oncol. 2003. PMID: 12598351 Free article. Clinical Trial.
A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: report of the Clinical Screening Group of the EORTC.
Fumoleau P, Chevallier B, Kerbrat P, Krakowski Y, Misset JL, Maugard-Louboutin C, Dieras V, Azli N, Bougon N, Riva A, Roche H. Fumoleau P, et al. Among authors: chevallier b. Ann Oncol. 1996 Feb;7(2):165-71. doi: 10.1093/oxfordjournals.annonc.a010544. Ann Oncol. 1996. PMID: 8777173 Free article. Clinical Trial.
Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. The Clinical Screening Group of the European Organization for Research and Treatment of Cancer.
Hurteloup P, Armand JP, Schneider M, Bastit P, Chevallier B, Pourny C, Keiling R, de Oliveira C, Hayat M, Thomas D, et al. Hurteloup P, et al. Among authors: chevallier b. Eur J Cancer Clin Oncol. 1989 Mar;25(3):423-8. doi: 10.1016/0277-5379(89)90254-x. Eur J Cancer Clin Oncol. 1989. PMID: 2702996
High-dose intensity regimens with epirubicin in ovarian cancer.
Vermorken JB, Bolis G, van Rijswijk RE, Kobierska A, Chevallier B, van der Burg ME, Zanaboni F, Lentz MA, Burger CW, Kenemans P, et al. Vermorken JB, et al. Among authors: chevallier b. Semin Oncol. 1994 Feb;21(1 Suppl 1):17-22. Semin Oncol. 1994. PMID: 8153653 Review. No abstract available.
Pirarubicin in advanced breast cancer: a French cooperative phase II study.
Spielmann M, Kerbrat P, Delozier T, Fumoleau P, Monnier A, Chevallier B, Bastit P, Namer M, Cattan A, Lucas P, et al. Spielmann M, et al. Among authors: chevallier b. Eur J Cancer. 1990;26(7):821-3. doi: 10.1016/0277-5379(90)90161-l. Eur J Cancer. 1990. PMID: 2145903
Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: study of the Clinical Screening Group of the European Organization for Research and Treatment of Cancer (EORTC).
Chauvergne J, Fumoleau P, Cappelaere P, Metz R, Armand JP, Chevallier B, Kerbrat P, de Forni M, Lhommé C, Roche H, et al. Chauvergne J, et al. Among authors: chevallier b. Eur J Cancer. 1993;29A(3):350-4. doi: 10.1016/0959-8049(93)90384-r. Eur J Cancer. 1993. PMID: 8398333 Clinical Trial.
Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer: a phase II trial of the Clinical Screening Cooperative Group of the European Organization for Research and Treatment of Cancer.
Chevallier B, Fumoleau P, Kerbrat P, Dieras V, Roche H, Krakowski I, Azli N, Bayssas M, Lentz MA, Van Glabbeke M. Chevallier B, et al. J Clin Oncol. 1995 Feb;13(2):314-22. doi: 10.1200/JCO.1995.13.2.314. J Clin Oncol. 1995. PMID: 7844592 Clinical Trial.
227 results